ApoE4: an emerging therapeutic target for Alzheimer’s disease

BACKGROUND: The growing body of evidence indicating the heterogeneity of Alzheimer’s disease (AD), coupled with disappointing clinical studies directed at a fit-for-all therapy, suggest that the development of a single magic cure suitable for all cases may not be possible. This calls for a shift in...

Descripción completa

Detalles Bibliográficos
Autores principales: Safieh, Mirna, Korczyn, Amos D., Michaelson, Daniel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425600/
https://www.ncbi.nlm.nih.gov/pubmed/30890171
http://dx.doi.org/10.1186/s12916-019-1299-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425600/
https://www.ncbi.nlm.nih.gov/pubmed/30890171
http://dx.doi.org/10.1186/s12916-019-1299-4

Ejemplares similares